|
Volumn 52, Issue 8, 2011, Pages 1421-1422
|
Inhibition of histone deacetylase 6 as a therapeutic strategy for acute lymphocytic leukemia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE TRIPHOSPHATASE;
ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM);
ALPHA TUBULIN;
DOUBLE STRANDED DNA;
HISTONE DEACETYLASE 6;
HISTONE DEACETYLASE 6 INHIBITOR;
HISTONE DEACETYLASE INHIBITOR;
PEROXIREDOXIN;
PROTEASOME INHIBITOR;
TUBACIN;
UNCLASSIFIED DRUG;
ACUTE LYMPHOCYTIC LEUKEMIA;
AGGRESOME;
APOPTOSIS;
B CELL LEUKEMIA;
CANCER CELL CULTURE;
CELL PROLIFERATION;
CELL SURVIVAL;
DEACETYLATION;
DISEASE SEVERITY;
DNA DAMAGE;
DRUG POTENTIATION;
ENZYME INHIBITION;
HEMATOLOGIC MALIGNANCY;
HISTONE ACETYLATION;
HUMAN;
LYMPHOCYTE DIFFERENTIATION;
LYSOSOME;
MICROTUBULE;
MULTIPLE MYELOMA;
NOTE;
PLEIOTROPY;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROTEIN ASSEMBLY;
PROTEIN DEGRADATION;
PROTEIN DOMAIN;
PROTEIN PROTEIN INTERACTION;
PROTEIN TARGETING;
PROTEIN TRANSPORT;
T CELL LEUKEMIA;
ANILIDES;
ANIMALS;
APOPTOSIS;
CELL PROLIFERATION;
HUMANS;
HYDROXAMIC ACIDS;
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;
|
EID: 79960422117
PISSN: 10428194
EISSN: 10292403
Source Type: Journal
DOI: 10.3109/10428194.2011.577259 Document Type: Note |
Times cited : (8)
|
References (8)
|